This survey collects information on how a treatment unit operates, the make-up of the unit staff and treatment population.

The TSR is an interview used to gather information about specific services provided to patients attending substance abuse and other types of treatment programs. The TSR focuses on services for seven potential problem areas-medical status, employment and support, drug use, alcohol use, legal status, family/social status, and psychiatric status-that correspond to the seven patient functioning areas assessed by the Addiction Severity Index. Patients are asked about the services that they received in the past week either in a program or outside of a program through referral. The TSR consists of 56 items. It takes approximately 10 minutes to administer and 1 minute to score. In clinical settings, the TSR can be used to describe the types of services patients receive in a treatment program. In this way, it is possible to differentiate types of programs and to determine whether the patient problems presented at admission have been addressed during treatment. In research, the TSR has been used to evaluate different forms of experimental interventions to ensure that they are delivered in the manner originally specified and that they differ from the control or comparison conditions. In addition, the TSR can be used in studies designed to match patients to the treatment programs or services that benefit from them most. A revised version of the TSR (the TSR-6) was developed in 2008 and found to be both reliable and valid (Cacciola et al, 2008).

The primary purpose of the Treatment Program Clinician survey is to determine the knowledge level (Section A) and behavior (Section B) of the clinicians as it relates to Hepatitis C. Another purpose is to determine the clarity of the program’s guidelines regarding Hepatitis C services (Section C), the barriers to providing Hepatitis C services (Section D) and the opinions (Section E) from the clinician’s perspective.

The primary purpose of the Treatment Program Administrator survey is to describe the Treatment Program modality, staffing, services, and clientele (Sections A, B, and C); the types of services offered (Section E) and reimbursement received (Section D) for the targeted service areas; and, the guidelines (Section F), barriers (Section G) and opinions from the administrator’s perspective. The following are the questions we wish to answer regarding Hepatitis-C and the proposed analysis. Questions:

No information is available.

A Time Line Follow Back assessment used to evaluate the number of cigarettes per day and non-cigarette tobacco used.

This TLFB scale is designed to assess recent cigarette, marijuana, and other drug use. The TLFB can be administered by an interviewer, self-administered, or administered by computer. It asks clients to retrospectively estimate their drug, marijuana or cigarette use 7 days to 2 years prior to the interview date. For cigarettes and marijuana, individuals are asked to estimate the number of cigarettes or joints smoked per day. For all other drug use, only frequency of use is captured (i.e., used or did not use). At this time, quantity estimates of other drug use are not meaningful. It is user friendly and flexible, with easy feedback and uncomplicated interpretation. The TLFB can be used as a clinical and research tool to obtain a variety of quantitative estimates of marijuana, cigarette, and other drug use. These quantitative estimates and drug use-consumption variables can be used to measure change in drug, marijuana, and cigarette use levels in outcome monitoring and evaluation studies. In several studies, data obtained with a method like the TLFB have been sensitive to changes in drug and marijuana use. The TLFB can also be used in clinical settings as a motivational advice feedback tool to analyze clients’ marijuana, cigarette, and other drug use and to increase their motivation to change (e.g., feedback at assessment, comparative feedback such as before and during treatment). It has been adapted for use with dual diagnosis patients, and is a good index of treatment-related change.

Participants’ commitment to abstinence will be assessed with the Thoughts about Abstinence assessment (Hall et al., 1991), modified to assess the participants’ thoughts related to alcohol, illicit drugs, and cigarettes. This measure assesses the participant’s desire to quit, expected success in quitting and estimated difficulty in avoiding relapse. In addition, it assesses the client’s goal for her use ranging from no goal to complete abstinence for life. Significant increases in commitment to abstinence, as measured by this instrument, have been found for participants assigned to Motivational Interviewing compared to standard treatment (Saunders et al., 1995). The Thoughts about Abstinence assessment will be completed at screening and at the end of the active study phase.